Compounds > efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination

efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Mental-Disorders

efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination has been researched along with Mental-Disorders* in 1 studies

Other Studies

1 other study(ies) available for efavirenz--emtricitabine--tenofovir-disoproxil-fumarate-drug-combination and Mental-Disorders

ArticleYear
Single-tablet antiretroviral treatment (once daily).
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Sep-20, Volume: 188, Issue:13

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Interactions; Drug Resistance, Viral; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Mental Disorders; Oxazines; Piperazines; Pyridones; Viral Load

2016
chemdatabank.com